Ginkgo Bioworks Holdings annual revenue
2019
2020
2021
2022
2023
2024
2025
Ginkgo Bioworks Holdings Revenue Growth & History (DNA)
Ginkgo Bioworks Holdings reported $170.2M in revenue for fiscal 2025, a decrease of 25.06% from the previous fiscal year.
View full Ginkgo Bioworks Holdings company overviewGinkgo Bioworks Holdings annual revenue and growth
| Fiscal year | Period ended | Revenue | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $170.2M | −$56.9M | −25.06% |
| 2024 | 2024-12-31 | $227.0M | −$24.4M | −9.71% |
| 2023 | 2023-12-31 | $251.5M | −$226.3M | −47.36% |
| 2022 | 2022-12-31 | $477.7M | $163.9M | +52.21% |
| 2021 | 2021-12-31 | $313.8M | $237.2M | +309.40% |
| 2020 | 2020-12-31 | $76.7M | $22.5M | +41.48% |
| 2019 | 2019-12-31 | $54.2M | — | — |
Ginkgo Bioworks Holdings quarterly revenue
Q3.20
Q1.21
Q2.21
Q3.21
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Revenue | Change | YoY growth |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $20.2M | −$19.0M | −48.49% |
| Q1 2026 | 2026-03-31 | $19.5M | −$18.8M | −49.06% |
| Q4 2025 | 2025-12-31 | $54.0M | $10.1M | +23.05% |
| Q3 2025 | 2025-09-30 | $38.8M | −$50.2M | −56.39% |
| Q2 2025 | 2025-06-30 | $39.1M | −$17.1M | −30.37% |
| Q1 2025 | 2025-03-31 | $38.2M | $286,000 | +0.75% |
| Q4 2024 | 2024-12-31 | $43.8M | $9.1M | +26.16% |
| Q3 2024 | 2024-09-30 | $89.0M | $33.6M | +60.65% |
| Q2 2024 | 2024-06-30 | $56.2M | −$24.4M | −30.24% |
| Q1 2024 | 2024-03-31 | $37.9M | −$42.8M | −52.98% |
| Q4 2023 | 2023-12-31 | $34.8M | −$63.5M | −64.64% |
| Q3 2023 | 2023-09-30 | $55.4M | −$11.0M | −16.52% |
| Q2 2023 | 2023-06-30 | $80.6M | −$64.0M | −44.29% |
| Q1 2023 | 2023-03-31 | $80.7M | −$87.7M | −52.08% |
| Q4 2022 | 2022-12-31 | $98.3M | −$50.2M | −33.81% |
| Q3 2022 | 2022-09-30 | $66.4M | −$11.2M | −14.45% |
| Q2 2022 | 2022-06-30 | $144.6M | $101.0M | +231.42% |
| Q1 2022 | 2022-03-31 | $168.4M | $124.3M | +281.90% |
| Q4 2021 | 2021-12-31 | $148.5M | — | — |
| Q3 2021 | 2021-09-30 | $77.6M | $64.3M | +483.45% |
| Q2 2021 | 2021-06-30 | $43.6M | — | — |
| Q1 2021 | 2021-03-31 | $44.1M | — | — |
| Q3 2020 | 2020-09-30 | $13.3M | — | — |
Ginkgo Bioworks Holdings revenue growth trends
Over the last five reported fiscal years, revenue grew from $76.7M to $170.2M, a compound annual growth rate of 17.29%. Ginkgo Bioworks Holdings's latest reported quarter, Q2 2026, generated $20.2M in revenue, a decrease of 48.49% year over year.
About the data
What revenue means
Revenue is the top-line amount a company reports from selling goods and services before expenses are deducted. Fiscal periods can differ from calendar years, so each table includes the exact period end date.
Financial data
Standardized company financials
TickerStat standardizes company financial facts for consistent comparison. Derived growth rates use the displayed values and are not guidance or forecasts.
Review Ginkgo Bioworks Holdings source filings ↗Community posts
Ginkgo links laboratory data services with Lilly’s TuneLab platform
Ginkgo ($DNA) Bioworks entered an agreement to provide experimental data-generation services to companies using Lilly’s ($LLY) TuneLab AI drug-discovery platform. Its Datapoints offering will supply small-molecule and antibody developabilit ...
Ginkgo joins a federally backed RNA-manufacturing project worth up to $17.5 million
Ginkgo Bioworks ($DNA) received a subcontract worth up to $17.5 million to participate in an ARPA-H program focused on RNA manufacturing. Waterfall Scientific is the prime contractor. The project, called ESCALATOR, is intended to combine co ...
